ARTICLE
12 February 2026

Healthy AI: 2025 Year In Review

SM
Sheppard, Mullin, Richter & Hampton LLP

Contributor

Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more than 1,200 lawyers located in 16 offices worldwide, our client-centered approach is grounded in nearly a century of building enduring relationships on trust and collaboration. Our broad and diversified practices serve global clients—from startups to Fortune 500 companies—at every stage of the business cycle, including high-stakes litigation, complex transactions, sophisticated financings and regulatory issues. With leading edge technologies and innovation behind our team, we pride ourselves on being a strategic partner to our clients.
This publication provides an overview of important developments at the intersection of AI, healthcare and the law in 2025.
United States Food, Drugs, Healthcare, Life Sciences
Sheppard, Mullin, Richter & Hampton LLP are most popular:
  • within Cannabis & Hemp and Insolvency/Bankruptcy/Re-Structuring topic(s)

Artificial intelligence (AI) in healthcare may have reached an inflection point in 2025. After being defined by proofs of concept and isolated pilots for more than a decade, recent advances signal that AI is moving decisively into the operational core of health systems, life sciences organizations, and payer workflows. What once lived primarily in innovation labs and limited production environments is now increasingly embedded in day-to-day infrastructure across the industry.

This publication provides an overview of important developments at the intersection of AI, healthcare and the law in 2025. We cover key actions by the federal government and states as well as other industry developments and trends. Lastly, as healthcare businesses continue to explore and implement AI, we share insights into what we can expect in 2026.

2025 blog contributors include Carolyn Metnick, Megan Miller, Arushi Pandya, Alexandria Foster, Alyanna Gallo, Daniel Shemano, Tina Watson, Lena Zinner, Michael Sutton, Michael Orlando, Madeline Cunnion, Stephanie Awanyai-Ufondu, Esperance Becton, Christina Nguyen and Timothy Rozier-Byrd.

Click here to read more.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More